GlobeNewswire

Introducing the Future of the Heavy Building Materials Digital Supply Chain

Dela

Command Alkon's Reimagined Brand Identity Highlights its Leadership in their Industry's Transformation to Drive Rapid Innovation and Create First-Class Experiences

BIRMINGHAM, Ala., May 09, 2018 (GLOBE NEWSWIRE) -- Command Alkon, the global leader in integrated supply chain technology solutions for the Heavy Building Materials industry, is thrilled to reveal its reimagined brand, story and logo today. The company's new identity includes a mantra capturing the essence of "the why" for people across the building materials community, that "Together We Build Amazing." Today's unveiling celebrates the commitment from concrete producers, raw material suppliers, contractors and haulers to drive digital transformation - marking a meaningful moment for the industry, the company, and the people who collectively build our world.

"Drawing on the industry reputation and strength of relationships we've built in each segment of our business, we believe our reimagined brand further aides our goal to lead the digitization of our industry, create clearer understanding, grow the market and further attract the very best talent around the world," said Phil Ramsey, Chief Executive Officer at Command Alkon. "Updating our identity reflects where we've been, where we're headed, and aligns our story to our strategy."

Over the last four decades, Command Alkon has revolutionized heavy building materials with market-leading industry solutions. Building on the proven performance and collaborative industry partnerships nurtured in that time, Command Alkon is aligning the brand to their focus on delivering A+ experiences to customers and partners, alongside a unified face across solutions and locations around the world. The new logo and Command Alkon Tri-Con mark reflect these qualities.

The Power of a Symbol - http://embed.vidyard.com/share/jjYF3zanKXz2gYXV5gn692

Command Alkon's new mantra - "Together We Build Amazing," captures the essence of the industry's collective vision, where all participants impact and are impacted by one another. When collaboration and partnership are infused in daily intra-enterprise and inter-enterprise operations, goals are accomplished more efficiently and effectively, and greater prosperity is achieved.

The reimagined brand's driving force are industry heroes from Command Alkon's global customer community. They possess the wisdom, courage, confidence and grit to challenge the status quo, solve pervasive problems, and redefine the way business gets done. Command Alkon believes their heroes epitomize success, and are honored to be their partners in their quest to build an amazing world.

"Over the years, Command Alkon has placed an enormous value on crafting new innovations to increase productivity, improve future outcomes, and help our customers perform to the best of their ability," said Ed Rusch, Vice President of Marketing. "It's imperative for our identity to coordinate with our deep dedication to helping create amazing outcomes. The ability to thrive in a digital age, as well as positioning Command Alkon as the forward-thinking, human-centered technology company for the industry, is fundamental."

"Think you know Command Alkon?" - https://embed.vidyard.com/share/zr8wqh5jCajdGCr7GXMXZ1

To complement their reimagined brand reveal, Command Alkon has also launched an updated website that provides a more customer-focused, mobile-friendly and dynamic user experience, with stories organized around critical business and technology achievements. The website can be found at commandalkon.com.

Keep up with Command Alkon on Twitter and LinkedIn, and don't forget to subscribe to the resource  hub, envisioned to be an indispensable knowledge center for the heavy building material community.

ABOUT COMMAND ALKON

At Command Alkon, we believe in building an amazing world with solutions that deliver automation, visibility, collaboration and simplification to the Heavy Building Materials industry. Our integrated, digital supply chain solutions create an ecosystem for producers, suppliers and haulers of ready-mixed concrete, aggregates, asphalt, cement, and manufactured concrete, where operational transparency and efficiency drive profits. For over 40 years, our people, software and automation have kept clients moving to build the things that matter. Command Alkon is headquartered in Birmingham, Alabama and has offices in locations around the globe. For more information, visit commandalkon.com.

For More Information, Contact:

Becky Boyd
MediaFirst PR
(770) 642-2080 x 214
becky@mediafirst.net

Ed Rusch
Command Alkon
(205) 879-3282 x 2965
erusch@commandalkon.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Command Alkon via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Immunicum AB (publ) Announces Upcoming Investor Events in October and November22.10.2018 16:00Pressmeddelande

Press Release 22 October 2018 Immunicum AB (publ) Announces Upcoming Investor Events in October and November Immunicum AB (publ; IMMU.ST) announced today that the Company will participate in and host investor events in October and November. At all events Carlos de Sousa, CEO of Immunicum, and other members of the management team, will provide a corporate presentation and be available for a question and answer session. BioStock Life Science Summit Date: October 25, 2018 Presentation Time: 18.50 Central European Time Venue: Medicon Village, Scheelevägen 2, Building 302-auditorium, Lund, Sweden Registration Link: https://www.eventbrite.com/e/biostock-life-science-summit-tickets-51114333347 Immunicum Investor Event - Gothenburg Date: October 29, 2018 Presentation Time: 17.30 - 20.00 Central European Time Venue: First Hotel G, Nils Ericsonplatsen, 411 03 Gothenburg, Sweden Immunicum Investor Event - Stockholm Date: October 30, 2018 Presentation Time: 17.30 - 20.00 Central European Time Venu

Immunicum AB (publ) meddelar kommande investerarevent under oktober och november22.10.2018 16:00Pressmeddelande

Pressmeddelande 22 oktober 2018 Immunicum AB (publ) meddelar kommande investerarevent under oktober och november Immunicum AB (publ; IMMU.ST) meddelar i dag att bolaget kommer att anordna och delta i investerarträffar under oktober och november. Vid samtliga event kommer Carlos de Sousa, Immunicums VD, och övriga medlemmar av ledningsgruppen, att hålla en presentation av bolaget och vara tillgängliga för att svara på frågor. BioStock Life Science Summit Datum: 25 oktober 2018 Presentationstid: Kl. 18.50 CET Plats: Medicon Village, Scheelevägen 2, byggnad 302 - hörsalen, Lund Länk för registrering: https://www.eventbrite.com/e/biostock-life-science-summit-tickets-51114333347 Immunicums investerarevent - Göteborg Datum: 29 oktober 2018 Presentationstid: Kl. 17.30 - 20.00 CET Plats: First Hotel G, Nils Ericsonplatsen, 411 03, Göteborg Immunicums investerarevent - Stockholm Datum: 30 oktober 2018 Presentationstid: Kl. 17.30 - 20.00 CET Plats: Ingenjörshuset Citykonferensen, Plan 1, Malmski

Immunicum AB (publ) presenterar prekliniska resultat för ilixadencel i kombination med checkpointhämmare och immunaktiverare på 2018 års ESMO-kongress22.10.2018 12:45Pressmeddelande

Pressmeddelande 22 oktober 2018 Immunicum AB (publ) presenterar prekliniska resultat för ilixadencel i kombination med checkpointhämmare och immunaktiverare på 2018 års ESMO-kongress -- Intratumoral behandling med ilixadencel, en cellbaserad, lagringsbar immunaktiverare, ger en synergistisk antitumöreffekt och förstärker effekten av behandling med anti-PD-1 och anti-CD137 i djurmodeller -- Immunicum AB (publ; IMMU.ST) presenterar under 2018 års ESMO kongress (European Society for Medical Oncology) prekliniska resultat som visar en synergistisk anti-tumöreffekt när bolagets ledande produkt ilixadencel ges i kombination med en checkpointhämmare eller immunaktiverare. Resultaten från studien, som presenteras på en poster, visar att intratumoralt administrerat ilixadencel kan förstärka anti-tumörsvar och överlevnad vid behandling med checkpointhämmare eller immunaktiverare. Detta visar på potentialen hos ilixadencel att bli en komplementerande verkningsmekanism till flera olika framtida im

Immunicum AB (publ) Presents Preclinical Results of Ilixadencel in Combination with Checkpoint Inhibitors and Immune Enhancers at ESMO 201822.10.2018 12:45Pressmeddelande

Press Release 22 October 2018 Immunicum AB (publ) Presents Preclinical Results of Ilixadencel in Combination with Checkpoint Inhibitors and Immune Enhancers at ESMO 2018 -- Intratumoral treatment with ilixadencel, an off-the-shelf cell-based immune primer, provides synergistic anti-tumor effect and enhances efficacy of anti-PD-1 and anti-CD137 treatment in animal model -- Immunicum AB (publ; IMMU.ST) announced today the presentation of preclinical results that showed anti-tumor synergy between its lead product ilixadencel and a checkpoint inhibitor or an immune enhancer in a poster at the European Society for Medical Oncology (ESMO) 2018 Congress. The results of the study highlight the ability of intratumoral ilixadencel to enhance anti-tumor response and survival of systemic checkpoint inhibitors (anti-PD-1) or immune enhancers (anti-CD137/4-1BB). This emphasizes the potential for ilixadencel in multiple future immuno-oncology combination strategies by incorporating complementary mech

Karolinska Development's portfolio company OssDsign announces FDA clearance for Cranioplug22.10.2018 09:00Pressmeddelande

STOCKHOLM, October 22, 2018. Karolinska Development's portfolio company OssDsign announces that its latest product Cranioplug has received 510(k) clearance by the FDA, which allows marketing and sales of the product in US. The implant is the first product of its kind in the US market. Cranioplug is an implant used during neurosurgical procedures. The product is intended to cover and plug holes drilled into the skull during surgery and to reattach cranial bone removed during surgery. Cranioplug resorbs and is replaced with bone during the healing process. Anders Lundqvist, CEO of OssDsign, said: "Receiving clearance for Cranioplug is an important step for OssDsign. This motivates us to increase our presence in the US market and continue to build our US organization throughout 2018 and beyond. The regenerative features of OssDsign's calcium phosphate composition are now getting recognized, and it's our mission to turn them into real benefits for patients, surgeons and hospital systems."

Karolinska Development's portfolio company OssDsign announces FDA clearance for Cranioplug22.10.2018 09:00Pressmeddelande

STOCKHOLM, October 22, 2018. Karolinska Development's portfolio company OssDsign announces that its latest product Cranioplug has received 510(k) clearance by the FDA, which allows marketing and sales of the product in US. The implant is the first product of its kind in the US market. Cranioplug is an implant used during neurosurgical procedures. The product is intended to cover and plug holes drilled into the skull during surgery and to reattach cranial bone removed during surgery. Cranioplug resorbs and is replaced with bone during the healing process. Anders Lundqvist, CEO of OssDsign, said: "Receiving clearance for Cranioplug is an important step for OssDsign. This motivates us to increase our presence in the US market and continue to build our US organization throughout 2018 and beyond. The regenerative features of OssDsign's calcium phosphate composition are now getting recognized, and it's our mission to turn them into real benefits for patients, surgeons and hospital systems."

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum